Login / Signup

LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m 6 A-YTHDF2-dependent manner.

Yuan FangXi WuYunru GuRun ShiTao YuYutian PanJingxin ZhangXinming JingPei MaYongqian Shu
Published in: Clinical and translational medicine (2023)
A-YTHDF2-dependent manner, and targeting ALKBH5 may be a promising therapeutic method for GC patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • long non coding rna
  • prognostic factors
  • cell proliferation
  • cancer therapy
  • drug delivery
  • high resolution